We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.

Pfizer (Australia) BUPIVACAINE HYDROCHLORIDE 0.5% (50mg/10mL) injection BP ampoule (11312)

ARTG ID 11312

ARTG Name

Pfizer (Australia) BUPIVACAINE HYDROCHLORIDE 0.5% (50mg/10mL) injection BP ampoule

Product name

Pfizer (Australia) BUPIVACAINE HYDROCHLORIDE 0.5% (50mg/10mL) injection BP ampoule

ARTG Date

13 August 1991

Registration Type

Medicine

Therapeutic good type

Medicines

Ingredients

bupivacaine hydrochloride monohydrate

Licence category

RE

Licence status

A

Summary

Product Information

Consumer Medicine Information

Related information

Pfizer (Australia) BUPIVACAINE HYDROCHLORIDE 0.5% (50 mg/10 mL) injection BP ampoule, Pfizer Australia Pty Ltd, CON-1029

1 November 2022

Section 14 consent

Consent to import and supply while noncompliant with standards. The consent is effective from 1 November 2022 until 1 November 2023.
Pfizer (Australia) BUPIVACAINE HYDROCHLORIDE 0.5% (50mg/10mL) injection BP ampoule, Pfizer Australia Pty Ltd, CON-1383

10 July 2025

Section 14 consent

Consent to supply while noncompliant with standards. The consent is effective from 10 July 2025 until 30 September 2026.